Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 27.07.2026 1 Am J Dermatopathol 1 Biochem Biophys Res Commun 1 BMC Cancer 1 Br J Dermatol 1 Cancer 1 Cancer Lett 2 Cutis 1 J Invest Dermatol 1 J Surg Oncol 2 Melanoma Res 1 Oncogene 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. GERAMI P, Braat J, Holic LJ, Trichy NS, et al
   Morphologic and Molecular Differences of BAP1 Melanocytomas and BAP1 Inactivated Melanomas.
   Am J Dermatopathol. 2026 Jul 23. doi: 10.1097/DAD.0000000000003390.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. VAN LE T, Deviatiiarov R, Tomoyoshi Y, Gusev O, et al
   Cooperative IFN-gamma and TLR9 signaling reprogram tumor-associated macrophages to enhance antitumor immunity in melanoma.
   Biochem Biophys Res Commun. 2026;831:154245.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. LI Z, Zhu Z, Zhao R, Wang L, et al
   FOXM1-associated melanoma stratification: integrated multi-omics and experimental validation reveal prognostic significance and therapeutic potential.
   BMC Cancer. 2026 Jul 21. doi: 10.1186/s12885-026-16465.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

4. LODDE G, Livingstone E, Stang A
   Melanoma of unknown primary: UV-driven genomics and the need for era-adjusted outcomes: reply from authors.
   Br J Dermatol. 2026 Jul 23:ljag292. doi: 10.1093.
   PubMed        
   
   

   
   Cancer

5. LI S, Rojek AE, Shaw R, O'Donoghue C, et al
   Tumor-infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions.
   Cancer. 2026;132:e70526.
   PubMed         Abstract available
   
   

   
   Cancer Lett

6. VAN TRIMPONT M, Schalk AM, Hofkens K, Peeters E, et al
   A human-like glutaminase-free asparaginase is highly efficacious in ASNS(low) leukemia and solid cancer mouse xenograft models.
   Cancer Lett. 2024 Dec 19:217404. doi: 10.1016/j.canlet.2024.217404.
   PubMed         Abstract available
   
   

   
   Cutis

7. VERMA KK, Panchal SS, Friedmann DP, Tarbox MB, et al
   A Cost-Effectiveness and Psychological Evaluation of Early Skin Biopsies vs Later-Onset Surgeries in Melanoma Management.
   Cutis. 2026;117:E4-E5.
   PubMed        
   
   
8. PATEL D, Fayed AM, Alani O, Pathak N, et al
   Alignment of ChatGPT Responses With AAD Guidelines for Cutaneous Melanoma.
   Cutis. 2026;117:150-152.
   PubMed        
   
   

   
   J Invest Dermatol

9. O'HAGAN R, Mehta J, Acciardi A, Rodriguez MT, et al
   Depth-aware melanoma classification and Breslow depth estimation from reflectance confocal microscopy.
   J Invest Dermatol. 2026 Jul 21:S0022-202X(26)02680.
   PubMed        
   
   

   
   J Surg Oncol

10. CANTILLON OT, Busam KJ, Ariyan CE, Bartlett EK, et al
    Neoadjuvant Immune Therapy in Patients With Melanoma: Response and Toxicity in a Non-Clinical Trial Setting.
    J Surg Oncol. 2026 Jul 19. doi: 10.1002/jso.70324.
    PubMed         Abstract available
    
    

    
    Melanoma Res

11. KIM HE, Kim J, Lee DH, Shim HJ, et al
    Scalp melanoma presents with greater Breslow thickness and higher metastatic burden: analysis of 105 Korean cutaneous head and neck melanoma patients.
    Melanoma Res. 2026 Jul 23. doi: 10.1097/CMR.0000000000001126.
    PubMed         Abstract available
    
    
12. BONKAT N, Hafele J, Tancevski I
    Hemophagocytic lymphohistiocytosis and posterior reversible encephalopathy syndrome during BRAF/MEK inhibitor therapy following immune checkpoint blockade in metastatic melanoma: a case report.
    Melanoma Res. 2026 Jul 23. doi: 10.1097/CMR.0000000000001120.
    PubMed         Abstract available
    
    

    
    Oncogene

13. SABU KATTUMAN EE, Teegala LR, Katari V, Darzi S, et al
    Autocrine CysLT(1)R-ERK/YAP signaling drives melanoma progression and reveals a targetable oncogenic GPCR axis.
    Oncogene. 2026 Jul 24. doi: 10.1038/s41388-026-03919.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

14. SHETTIGAR M, Mouliere S, Isenegger L, DeVine AL, et al
    Oncogenic Galpha signaling requires AP-3-dependent recruitment to the endolysosomal compartment.
    Proc Natl Acad Sci U S A. 2026;123:e2615774123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum